Log in

NASDAQ:RARXRa Pharmaceuticals SEC Filings & 10K Form

$47.99
0.00 (0.00 %)
(As of 04/2/2020)
Add
Compare
Today's Range
$47.99
Now: $47.99
$47.99
50-Day Range
$47.99
MA: $47.99
$48.00
52-Week Range
$19.64
Now: $47.99
$48.02
Volume30,200 shs
Average Volume1.16 million shs
Market Capitalization$2.27 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.05

SEC Filings

Ra Pharmaceuticals (NASDAQ:RARX) SEC Filings

DateFilerForm TypeView
04/13/2020
5:01 AM
Ra Pharmaceuticals (Filer)
Form 15-12B
04/08/2020
11:15 PM
Ra Pharmaceuticals (Filer)
Form EFFECT
04/06/2020
1:08 PM
NEW ENTERPRISE ASSOCIATES 13 LP (Filed by)
Ra Pharmaceuticals (Subject)
Form SC 13D/A
04/03/2020
3:44 PM
Ra Pharmaceuticals (Filer)
Form 10-K/A
04/03/2020
8:28 AM
BASKETT FOREST (Reporting)
KERINS PATRICK J (Reporting)
NEA 13 GP, Ltd (Reporting)
NEA Partners 13, Limited Partnership (Reporting)
NEW ENTERPRISE ASSOCIATES 13 LP (Reporting)
Ra Pharmaceuticals (Issuer)
SANDELL SCOTT D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2020
8:03 AM
Mathers Edward T (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2020
8:02 AM
Ra Pharmaceuticals (Issuer)
Treco Douglas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2020
8:02 AM
Lubner David Charles (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2020
8:02 AM
Ra Pharmaceuticals (Issuer)
Ricardo Alonso (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2020
8:02 AM
Ra Pharmaceuticals (Issuer)
Read Simon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2020
8:01 AM
Farzaneh-Far Ramin (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2020
8:01 AM
Cumbo Alexander (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2020
8:01 AM
PEARSON TIMOTHY R (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2020
8:01 AM
King John C (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2020
8:00 AM
Ra Pharmaceuticals (Issuer)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2020
8:00 AM
Heft Robert (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2020
8:00 AM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2020
8:00 AM
Brennan Aoife (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2020
8:13 AM
Ra Pharmaceuticals (Subject)
The Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
03/31/2020
5:01 AM
Ra Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2020
5:00 PM
Ra Pharmaceuticals (Issuer)
Ricardo Alonso (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2020
5:00 PM
Farzaneh-Far Ramin (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
5:24 AM
Ra Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/20/2020
5:52 PM
Farzaneh-Far Ramin (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2020
6:32 AM
BlackRock Inc. (Filed by)
Ra Pharmaceuticals (Subject)
Form SC 13G/A
01/21/2020
5:32 PM
Ra Pharmaceuticals (Issuer)
Ricardo Alonso (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2020
5:01 PM
Farzaneh-Far Ramin (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2019
5:01 PM
Ra Pharmaceuticals (Issuer)
Ricardo Alonso (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2019
5:01 PM
Ra Pharmaceuticals (Issuer)
Read Simon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2019
5:00 PM
Farzaneh-Far Ramin (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2019
5:04 AM
Ra Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2019
4:13 PM
Ra Pharmaceuticals (Filer)
Form DEFA14A
11/25/2019
5:04 AM
Ra Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2019
4:08 PM
Farzaneh-Far Ramin (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
4:07 PM
Ra Pharmaceuticals (Issuer)
Read Simon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2019
7:03 AM
Ra Pharmaceuticals (Filer)
Form DEFM14A
11/08/2019
8:04 AM
Ra Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/07/2019
5:17 AM
Ra Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2019
7:24 AM
Ra Pharmaceuticals (Filer)
Form PREM14A
10/17/2019
7:11 PM
Ra Pharmaceuticals (Issuer)
Ricardo Alonso (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2019
6:00 PM
Ra Pharmaceuticals (Issuer)
Read Simon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2019
6:00 PM
Farzaneh-Far Ramin (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2019
1:11 PM
NEW ENTERPRISE ASSOCIATES 13 LP (Filed by)
Ra Pharmaceuticals (Subject)
Form SC 13D/A
10/11/2019
3:12 PM
RA CAPITAL MANAGEMENT, LLC (Filed by)
Ra Pharmaceuticals (Subject)
Form SC 13D/A
10/10/2019
8:05 AM
Ra Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2019
8:03 AM
Ra Pharmaceuticals (Filer)
Form DEFA14A
09/16/2019
5:44 PM
Farzaneh-Far Ramin (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2019
5:43 PM
Ra Pharmaceuticals (Issuer)
Read Simon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2019
5:01 PM
Ra Pharmaceuticals (Issuer)
Read Simon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2019
5:01 PM
Farzaneh-Far Ramin (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2019
5:00 PM
Ra Pharmaceuticals (Issuer)
Ricardo Alonso (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
5:52 AM
Ra Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/26/2019
9:53 AM
Ra Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2019
3:41 PM
Ra Pharmaceuticals (Filer)
Form 424B5
07/22/2019
8:36 PM
Ra Pharmaceuticals (Filer)
Form 424B5
07/18/2019
6:04 PM
Ra Pharmaceuticals (Issuer)
Read Simon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2019
6:15 PM
Farzaneh-Far Ramin (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2019
6:15 AM
Ra Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2019
3:16 PM
Ra Pharmaceuticals (Issuer)
Ricardo Alonso (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
8:03 PM
Ra Pharmaceuticals (Issuer)
Read Simon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
8:03 PM
Farzaneh-Far Ramin (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:36 PM
Ra Pharmaceuticals (Issuer)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:35 PM
Cumbo Alexander (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:35 PM
PEARSON TIMOTHY R (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:34 PM
Brennan Aoife (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:33 PM
Heft Robert (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:30 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, LLC (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:11 PM
Mathers Edward T (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
4:18 PM
Ra Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
4:14 PM
Ra Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/09/2019
4:11 PM
Ra Pharmaceuticals (Filer)
Form 424B5
05/09/2019
3:42 PM
Ra Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
3:08 PM
Ra Pharmaceuticals (Filer)
Form S-3ASR
05/09/2019
5:27 AM
Ra Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2019
2:47 PM
Ra Pharmaceuticals (Filer)
Form DEFA14A
04/26/2019
2:42 PM
Ra Pharmaceuticals (Filer)
Form DEF 14A
04/18/2019
4:55 PM
King John C (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2019
3:51 PM
MORGENTHALER VENTURE PARTNERS IX LP (Filed by)
Ra Pharmaceuticals (Subject)
Form SC 13D/A
03/07/2019
6:20 AM
Ra Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2019
5:06 PM
Ra Pharmaceuticals (Issuer)
Ricardo Alonso (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/05/2019
6:40 PM
King John C (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
6:39 PM
Lubner David Charles (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
6:39 PM
Ra Pharmaceuticals (Issuer)
Read Simon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
6:38 PM
Farzaneh-Far Ramin (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
6:38 PM
Ra Pharmaceuticals (Issuer)
Treco Douglas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2019
3:54 PM
MORGENTHALER VENTURE PARTNERS IX LP (Filed by)
Ra Pharmaceuticals (Subject)
Form SC 13D/A
01/07/2019
4:05 PM
MORGENTHALER VENTURE PARTNERS IX LP (Filed by)
Ra Pharmaceuticals (Subject)
Form SC 13D/A
12/14/2018
5:22 PM
BARRIS PETER J (Reporting)
BASKETT FOREST (Reporting)
KERINS PATRICK J (Reporting)
MOTT DAVID M (Reporting)
NEA 13 GP, Ltd (Reporting)
NEA Partners 13, Limited Partnership (Reporting)
NEW ENTERPRISE ASSOCIATES 13 LP (Reporting)
Ra Pharmaceuticals (Issuer)
SANDELL SCOTT D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
5:17 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, LLC (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
5:14 PM
Ra Pharmaceuticals (Issuer)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
5:03 AM
Ra Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2018
4:31 PM
Ra Pharmaceuticals (Filer)
Form 424B5
12/11/2018
4:24 PM
Ra Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2018
3:15 PM
Ra Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2018
3:34 PM
Cumbo Alexander (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2018
3:32 PM
Cumbo Alexander (Reporting)
Ra Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/15/2018
3:30 PM
Ra Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2018
3:12 PM
Ra Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2018
7:01 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, LLC (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2018
8:20 AM
Brennan Aoife (Reporting)
Ra Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 6/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.